Filana Therapeutics Appoints Jill M. Quigley to Board
at www.tipranks.com (Thu, 12-Nov 9:41 AM)
FLNA jumps after FDA lifts clinical hold, clearing a 40-patient Phase 2a path for simufilam in TSC-related epilepsy
Market Chameleon (Tue, 22-Sep 9:53 AM)
